rs4523096

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_182961.4(SYNE1):​c.1463+24G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.727 in 1,584,074 control chromosomes in the GnomAD database, including 422,704 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.79 ( 48411 hom., cov: 31)
Exomes 𝑓: 0.72 ( 374293 hom. )

Consequence

SYNE1
NM_182961.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.0790

Publications

14 publications found
Variant links:
Genes affected
SYNE1 (HGNC:17089): (spectrin repeat containing nuclear envelope protein 1) This gene encodes a spectrin repeat containing protein expressed in skeletal and smooth muscle, and peripheral blood lymphocytes, that localizes to the nuclear membrane. Mutations in this gene have been associated with autosomal recessive spinocerebellar ataxia 8, also referred to as autosomal recessive cerebellar ataxia type 1 or recessive ataxia of Beauce. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008]
SYNE1 Gene-Disease associations (from GenCC):
  • autosomal recessive ataxia, Beauce type
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, G2P, Orphanet, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae)
  • arthrogryposis multiplex congenita 3, myogenic type
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • Emery-Dreifuss muscular dystrophy 4, autosomal dominant
    Inheritance: AD Classification: MODERATE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Illumina
  • autosomal dominant Emery-Dreifuss muscular dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal recessive myogenic arthrogryposis multiplex congenita
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 6-152472277-C-A is Benign according to our data. Variant chr6-152472277-C-A is described in ClinVar as Benign. ClinVar VariationId is 262164.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.94 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SYNE1NM_182961.4 linkc.1463+24G>T intron_variant Intron 15 of 145 ENST00000367255.10 NP_892006.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SYNE1ENST00000367255.10 linkc.1463+24G>T intron_variant Intron 15 of 145 1 NM_182961.4 ENSP00000356224.5 Q8NF91-1

Frequencies

GnomAD3 genomes
AF:
0.790
AC:
120007
AN:
151966
Hom.:
48363
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.943
Gnomad AMI
AF:
0.609
Gnomad AMR
AF:
0.731
Gnomad ASJ
AF:
0.738
Gnomad EAS
AF:
0.962
Gnomad SAS
AF:
0.790
Gnomad FIN
AF:
0.794
Gnomad MID
AF:
0.766
Gnomad NFE
AF:
0.701
Gnomad OTH
AF:
0.783
GnomAD2 exomes
AF:
0.759
AC:
189973
AN:
250272
AF XY:
0.758
show subpopulations
Gnomad AFR exome
AF:
0.948
Gnomad AMR exome
AF:
0.697
Gnomad ASJ exome
AF:
0.738
Gnomad EAS exome
AF:
0.966
Gnomad FIN exome
AF:
0.791
Gnomad NFE exome
AF:
0.707
Gnomad OTH exome
AF:
0.743
GnomAD4 exome
AF:
0.720
AC:
1031097
AN:
1431990
Hom.:
374293
Cov.:
25
AF XY:
0.722
AC XY:
515819
AN XY:
714424
show subpopulations
African (AFR)
AF:
0.954
AC:
31327
AN:
32850
American (AMR)
AF:
0.702
AC:
31289
AN:
44594
Ashkenazi Jewish (ASJ)
AF:
0.737
AC:
19137
AN:
25958
East Asian (EAS)
AF:
0.979
AC:
38749
AN:
39566
South Asian (SAS)
AF:
0.784
AC:
66869
AN:
85284
European-Finnish (FIN)
AF:
0.785
AC:
41874
AN:
53368
Middle Eastern (MID)
AF:
0.786
AC:
4484
AN:
5706
European-Non Finnish (NFE)
AF:
0.694
AC:
752907
AN:
1085274
Other (OTH)
AF:
0.749
AC:
44461
AN:
59390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
14276
28553
42829
57106
71382
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19048
38096
57144
76192
95240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.790
AC:
120115
AN:
152084
Hom.:
48411
Cov.:
31
AF XY:
0.794
AC XY:
59010
AN XY:
74346
show subpopulations
African (AFR)
AF:
0.943
AC:
39153
AN:
41524
American (AMR)
AF:
0.730
AC:
11154
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.738
AC:
2561
AN:
3472
East Asian (EAS)
AF:
0.963
AC:
4986
AN:
5180
South Asian (SAS)
AF:
0.790
AC:
3804
AN:
4816
European-Finnish (FIN)
AF:
0.794
AC:
8381
AN:
10560
Middle Eastern (MID)
AF:
0.762
AC:
224
AN:
294
European-Non Finnish (NFE)
AF:
0.701
AC:
47650
AN:
67948
Other (OTH)
AF:
0.781
AC:
1647
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1200
2400
3600
4800
6000
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
860
1720
2580
3440
4300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.753
Hom.:
49001
Bravo
AF:
0.793
Asia WGS
AF:
0.867
AC:
3014
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Jun 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Arthrogryposis multiplex congenita 3, myogenic type Benign:1
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal recessive ataxia, Beauce type Benign:1
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Emery-Dreifuss muscular dystrophy 4, autosomal dominant Benign:1
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.20
DANN
Benign
0.60
PhyloP100
0.079
PromoterAI
-0.060
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4523096; hg19: chr6-152793412; API